Metzger Michael A
- SEC CIK
- 0001507220
In the past year, 4 open-market sale filings worth $1.43M and no purchases.
Current role at each company
- SNDX Syndax Pharmaceuticals IncChief Executive Officeras of Jul 9, 2026
- PYXS Pyxis Oncology, Inc.Directoras of Mar 25, 2026
- CTIC Cti Biopharma CorpDirectoras of Jun 26, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.43M
- 4 filings
- Net
- −$1.43M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Metzger Michael A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SNDX Syndax Pharmaceuticals Inc
Chief Executive Officer19 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 (view filing) | Sep 13-14 | 2 days | Metzger Michael APresident and COO | SSale | −61.0K | $19.11 | −$1.17M | −77.5%17.7K after | 2 lots |
| Sep 22, 2021 (view filing) | Sep 20-22 | 2 days | Metzger Michael APresident and COO | SSale | −36.6K | $19.23 | −$703.0K | −67.4%17.7K after | 3 lots |
| Sep 28, 2021 (view filing) | Sep 27 | 1 day | Metzger Michael APresident and COO | SSale | −24.4K | $19.51 | −$476.8K | −58.1%17.7K after | |
| Oct 27, 2021 (view filing) | Oct 25-26 | 2 days | Metzger Michael APresident and COO | SSale | −61.0K | $19.15 | −$1.17M | −77.5%17.7K after | 2 lots |
| Dec 15, 2021 (view filing) | Dec 13 | 2 days | Metzger Michael APresident and COO | SSale | −36.6K | $19.05 | −$697.4K | −67.5%17.7K after | 2 lots |
| Dec 20, 2021 (view filing) | Dec 16-20 | 4 days | Metzger Michael APresident and COO | SSale | −85.4K | $19.94 | −$1.70M | −82.9%17.7K after | 4 lots |
| Jul 8, 2022 (view filing) | Jul 6-7 | 2 days | Metzger Michael AChief Executive Officer | SSale | −15.1K | $21.07 | −$318.3K | −46.1%17.7K after | 2 lots |
| Jul 27, 2022 (view filing) | Jul 25 | 2 days | Metzger Michael AChief Executive Officer | SSale | −31.6K | $21.06 | −$665.5K | −64.2%17.7K after | 2 lots |
| Oct 4, 2022 (view filing) | Sep 30-Oct 4 | 4 days | Metzger Michael AChief Executive Officer | SSale | −33.8K | $25.02 | −$844.9K | −65.7%17.7K after | 3 lots |
| Oct 7, 2022 (view filing) | Oct 6 | 1 day | Metzger Michael AChief Executive Officer | SSale | −16.2K | $25.29 | −$410.5K | −47.9%17.7K after |
CTIC Cti Biopharma Corp
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Metzger Michael ADirector | SSale | −91.5K | $6.08 | −$556.0K | −82.0%20.1K after | 4 lots |
| Jul 11, 2022 (view filing) | Jul 7 | 4 days | Metzger Michael ADirector | SSale | −20.1K | $6.51 | −$131.0K | −100.0%0 after | 6 lots |
| Nov 10, 2022 (view filing) | Nov 8 | 2 days | Metzger Michael ADirector | SSale | −91.5K | $5.59 | −$511.2K | −100.0%0 after | 3 lots |